150 related articles for article (PubMed ID: 34225971)
1. The circadian system in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Fifel K; De Boer T
Handb Clin Neurol; 2021; 179():301-313. PubMed ID: 34225971
[TBL] [Abstract][Full Text] [Related]
2. Circadian alterations in patients with neurodegenerative diseases: Neuropathological basis of underlying network mechanisms.
Fifel K; Videnovic A
Neurobiol Dis; 2020 Oct; 144():105029. PubMed ID: 32736083
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the circadian system in Parkinson's disease patients.
Fifel K
Mov Disord; 2017 May; 32(5):682-692. PubMed ID: 27859638
[TBL] [Abstract][Full Text] [Related]
4. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
5. Free-water imaging in Parkinson's disease and atypical parkinsonism.
Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
[TBL] [Abstract][Full Text] [Related]
6. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
[TBL] [Abstract][Full Text] [Related]
7. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
De Pablo-Fernández E; Courtney R; Warner TT; Holton JL
JAMA Neurol; 2018 Aug; 75(8):1008-1012. PubMed ID: 29710120
[TBL] [Abstract][Full Text] [Related]
8. Gait and postural disorders in parkinsonism: a clinical approach.
Raccagni C; Nonnekes J; Bloem BR; Peball M; Boehme C; Seppi K; Wenning GK
J Neurol; 2020 Nov; 267(11):3169-3176. PubMed ID: 31119450
[TBL] [Abstract][Full Text] [Related]
9. The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes.
Diez-Fairen M; Alvarez Jerez P; Berghausen J; Bandres-Ciga S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360863
[TBL] [Abstract][Full Text] [Related]
10. Functional Connectome in Parkinson's Disease and Parkinsonism.
Tinaz S
Curr Neurol Neurosci Rep; 2021 Apr; 21(6):24. PubMed ID: 33817766
[TBL] [Abstract][Full Text] [Related]
11. [Recent neuropathology of parkinsonian syndromes].
Duyckaerts C; Verny M; Hauw JJ
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S11-8. PubMed ID: 12773883
[TBL] [Abstract][Full Text] [Related]
12. Diffusion tensor imaging differentiates vascular parkinsonism from parkinsonian syndromes of degenerative origin in elderly subjects.
Deverdun J; Menjot de Champfleur S; Cabello-Aguilar S; Maury F; Molino F; Charif M; Leboucq N; Ayrignac X; Labauge P; Bonafe A; Castelnovo G; Le Bars E; Geny C; Menjot de Champfleur N
Eur J Radiol; 2014 Nov; 83(11):2074-9. PubMed ID: 25154005
[TBL] [Abstract][Full Text] [Related]
13. Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism.
Du G; Lewis MM; Kanekar S; Sterling NW; He L; Kong L; Li R; Huang X
AJNR Am J Neuroradiol; 2017 May; 38(5):966-972. PubMed ID: 28364007
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.
Turcano P; Mielke MM; Josephs KA; Bower JH; Parisi JE; Boeve BF; Savica R
Mov Disord; 2017 Oct; 32(10):1439-1446. PubMed ID: 28843020
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
Savoiardo M
Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility variants in parkinsonism.
Soto-Ortolaza AI; Ross OA
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S7-11. PubMed ID: 26414118
[TBL] [Abstract][Full Text] [Related]
17. Recognizing and treating atypical Parkinson disorders.
Armstrong MJ; McFarland N
Handb Clin Neurol; 2019; 167():301-320. PubMed ID: 31753139
[TBL] [Abstract][Full Text] [Related]
18. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
Wenning GK; Colosimo C
Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
[TBL] [Abstract][Full Text] [Related]
20. Flt3 ligand does not differentiate between Parkinsonian disorders.
Silajdžić E; Constantinescu R; Holmberg B; Björkqvist M; Hansson O
Mov Disord; 2014 Sep; 29(10):1319-22. PubMed ID: 25044107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
